Remicade linked to even more cancers…

A recent study conducted by the Mayo clinic revealed that a patint on Remicade may be 3 times more likely to developing cancer than someone who is not.

Of course the study is being argued as flawed by the makers of Remicade.

Initially, drug labels did warn against lymphoma, and infections such as tuberculosis and pneumonia. However, this recent research links Remicade to other cancers, too, including skin, gastrointestinal, breast, and lung tumors.